Ayşegül Yıldız
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ayşegül Yıldız has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Fatmanur Tuğcu-Demiröz
Gazi University Faculty of Pharmacy, Department of Pharmaceutical Technology, Ankara, Türkiye
5 shared publications - Füsun Acartürk
Gazi University Faculty of Pharmacy, Department of Pharmaceutical Technology, Ankara, Türkiye
5 shared publications Adnan Altuğ Kara
Gazi University, Faculty of Pharmacy, Department of Pharmaceutical Technology, 06330- Etiler, Ankara, TURKEY
2 shared publicationsFüsun Acartürk
2 shared publications- Serdar Tort
Gazi University Faculty of Pharmacy, Department of Pharmaceutical Technology, Ankara, Türkiye
2 shared publications - Sinem Saar
Gazi University Faculty of Pharmacy, Department of Pharmaceutical Technology, Ankara, Türkiye
2 shared publications
Latest Publications
- Open Access
- 6 June 2026
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 21 (6)
Development of Eudragit-Based Nanofiber Formulations for Colon-Targeted Delivery of Hydrocortisone in Inflammatory Bowel Disease
Purpose: Inflammatory bowel disease (IBD) is a chronic inflammatory disorder requiring effective localized drug delivery to minimize systemic side effects. This study aimed to develop pH-responsive, Eudragit-based nanofiber formulations for colon-targeted oral delivery of hydrocortisone (HC). Methods: HC-loaded nanofibers were fabricated using the electrospinning technique with Eudragit ® S100 and Eudragit ® L100-55 polymers. Physicochemical characterization was performed using Differential Scanning Calorimetry (DSC), Fourier Transform Infrared Spectroscopy (FT-IR), X-ray Diffraction (XRD), and Proton Nuclear Magnetic Resonance (¹H-NMR) analyses. Morphology, mechanical properties, contact angle, mucoadhesion, in vitro drug release, and ex vivo permeability were evaluated. Cytotoxicity and anti-inflammatory activity were assessed using RAW 264.7 macrophage cells. Results: XRD and DSC analyses indicated a reduction in the crystalline nature of HC within the nanofiber matrix, suggesting partial amorphization following electrospinning. The optimized formulation (E4) exhibited uniform morphology, suitable mechanical properties, and enhanced mucoadhesion. In vitro release studies demonstrated minimal drug release under gastric conditions (~ 11% at pH 1.2) and increased release at intestinal and colonic pH, confirming pH-responsive behavior. Ex vivo studies showed comparable permeability among formulations. Cell culture studies revealed that the formulations were non-cytotoxic (> 80% cell viability) and and significantly reduced TNF-α expression by approximately 39% at the protein level and showed a comparable reduction at the mRNA level. Conclusion: The developed Eudragit-based nanofiber system, particularly the E4 formulation, demonstrated effective colon-targeted delivery, favorable physicochemical properties, and significant anti-inflammatory activity. These findings indicate that HC-loaded nanofibers represent a promising platform for the localized treatment of IBD.
- 6 June 2026
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 21 (6)
Open AccessDevelopment of Eudragit-Based Nanofiber Formulations for Colon-Targeted Delivery of Hydrocortisone in Inflammatory Bowel Disease
Purpose: Inflammatory bowel disease (IBD) is a chronic inflammatory disorder requiring effective localized drug delivery to minimize systemic side effects. This study aimed to develop pH-responsive, Eudragit-based nanofiber formulations for colon-targeted oral delivery of hydrocortisone (HC). Methods: HC-loaded nanofibers were fabricated using the electrospinning technique with Eudragit ® S100 and Eudragit ® L100-55 polymers. Physicochemical characterization was performed using Differential Scanning Calorimetry (DSC), Fourier Transform Infrared Spectroscopy (FT-IR), X-ray Diffraction (XRD), and Proton Nuclear Magnetic Resonance (¹H-NMR) analyses. Morphology, mechanical properties, contact angle, mucoadhesion, in vitro drug release, and ex vivo permeability were evaluated. Cytotoxicity and anti-inflammatory activity were assessed using RAW 264.7 macrophage cells. Results: XRD and DSC analyses indicated a reduction in the crystalline nature of HC within the nanofiber matrix, suggesting partial amorphization following electrospinning. The optimized formulation (E4) exhibited uniform morphology, suitable mechanical properties, and enhanced mucoadhesion. In vitro release studies demonstrated minimal drug release under gastric conditions (~ 11% at pH 1.2) and increased release at intestinal and colonic pH, confirming pH-responsive behavior. Ex vivo studies showed comparable permeability among formulations. Cell culture studies revealed that the formulations were non-cytotoxic (> 80% cell viability) and and significantly reduced TNF-α expression by approximately 39% at the protein level and showed a comparable reduction at the mRNA level. Conclusion: The developed Eudragit-based nanofiber system, particularly the E4 formulation, demonstrated effective colon-targeted delivery, favorable physicochemical properties, and significant anti-inflammatory activity. These findings indicate that HC-loaded nanofibers represent a promising platform for the localized treatment of IBD.
- 27 January 2026
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 118
Silk fibroin: features, production methods and medical applications
- 27 January 2026
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 118
Silk fibroin: features, production methods and medical applications
- 1 January 2025
- Published by Ankara Universitesi Eczacilik Fakultesi Dergisi in Ankara Universitesi Eczacilik Fakultesi Dergisi
- Vol. 49 (3) , 25
OPTIMIZATION FORMULATION OF INSULIN-LOADED POLY-CAPROLACTONE NANOPARTICLES FOR CHRONIC WOUND HEALING USING BOX-BEHNKEN DESIGN
Objective: The aim of this study is to optimize the formulation of insulin-loaded poly-caprolactone nanoparticles (INS-PCL-NP) for use in chronic wound healing using Box-Behnken experimental design. Material and Method: The response of independent variables (poly-caprolactone concentration, polyvinyl alcohol concentration and sonication time) on dependent variables (particle size, PDI and encapsulation efficiency) were evaluated. Nanoparticle formulations were produced by the double emulsion (w/o/w)-solvent evaporation method. The resulting formulations were characterized in terms of particle size, zeta potential, and encapsulation efficiency to determine the optimum formulation. Further analyses, including morphological analyses, Fourier-transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), and in vitro drug release studies were conducted on the optimized formulation. Result and Discussion: According to the results of the characterization studies, it was observed that the optimized nanoparticles had a particle size of 618.5±11.2 nm, a PDI of 0.194±0.021, a zeta potential of -8.21±1.1 mV and an encapsulation efficiency of 73.1±4.2%. In morphological analysis, it was observed that the nanoparticles had a spherical structure. The optimized nanoparticle formulation showed a rapid release of 49.1±2.1% within the first 24 hours, followed by a controlled release for 168 hours.
- 1 January 2025
- Published by Ankara Universitesi Eczacilik Fakultesi Dergisi in Ankara Universitesi Eczacilik Fakultesi Dergisi
- Vol. 49 (3) , 25
OPTIMIZATION FORMULATION OF INSULIN-LOADED POLY-CAPROLACTONE NANOPARTICLES FOR CHRONIC WOUND HEALING USING BOX-BEHNKEN DESIGN
Objective: The aim of this study is to optimize the formulation of insulin-loaded poly-caprolactone nanoparticles (INS-PCL-NP) for use in chronic wound healing using Box-Behnken experimental design. Material and Method: The response of independent variables (poly-caprolactone concentration, polyvinyl alcohol concentration and sonication time) on dependent variables (particle size, PDI and encapsulation efficiency) were evaluated. Nanoparticle formulations were produced by the double emulsion (w/o/w)-solvent evaporation method. The resulting formulations were characterized in terms of particle size, zeta potential, and encapsulation efficiency to determine the optimum formulation. Further analyses, including morphological analyses, Fourier-transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), and in vitro drug release studies were conducted on the optimized formulation. Result and Discussion: According to the results of the characterization studies, it was observed that the optimized nanoparticles had a particle size of 618.5±11.2 nm, a PDI of 0.194±0.021, a zeta potential of -8.21±1.1 mV and an encapsulation efficiency of 73.1±4.2%. In morphological analysis, it was observed that the nanoparticles had a spherical structure. The optimized nanoparticle formulation showed a rapid release of 49.1±2.1% within the first 24 hours, followed by a controlled release for 168 hours.
- 27 October 2023
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 38 (5) , 646-661
Silk fibroin nanoparticles and β–tricalcium phosphate loaded tissue engineered gelatin bone scaffolds: A Nature-based, low-cost solution
Tissue engineering has recently attracted attention as an alternative to traditional treatment methods for tissue and organ damage. Since bone is one of the most important vital parts of the body, the treatment of bone damage is important. Silk fibroin is a natural polymer with properties such as biocompatibility and biodegradability, which attracts attention with its controlled release, especially in drug delivery systems. In this study, gelatin-based scaffolds loaded with silk fibroin nanoparticles and β -tricalcium phosphate (β -TCP) were developed to be used as a potential drug delivery system in bone tissue engineering. The chosen nanoparticle formulation has a 294 nm average diameter with a 0.380 polidispersity index (PDI). In vitro characterization of scaffolds was performed by mechanical, morphological characterization, swelling capacity, Differential Scanning Calorimetry (DSC), Fourier-Transform Infrared Spectroscopy (FT-IR) measurements, and biocompatibility was evaluated by cell culture studies. Swelling index, tensile strength, elongation at break, and Young modulus of the β -TCP and silk nanoparticles loaded scaffold were found as 456%, 1.476 MPa, 6.75%, and 24 MPa, respectively. In vitro cell culture studies have shown that scaffolds prepared in the present study can accelerate osteoblast differentiation and increase the healing rate of bone tissues. In addition, they have the potential to be used as a drug delivery system in bone tissue engineering that needs to be evaluated with further studies.
- 27 October 2023
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 38 (5) , 646-661
Silk fibroin nanoparticles and β–tricalcium phosphate loaded tissue engineered gelatin bone scaffolds: A Nature-based, low-cost solution
Tissue engineering has recently attracted attention as an alternative to traditional treatment methods for tissue and organ damage. Since bone is one of the most important vital parts of the body, the treatment of bone damage is important. Silk fibroin is a natural polymer with properties such as biocompatibility and biodegradability, which attracts attention with its controlled release, especially in drug delivery systems. In this study, gelatin-based scaffolds loaded with silk fibroin nanoparticles and β -tricalcium phosphate (β -TCP) were developed to be used as a potential drug delivery system in bone tissue engineering. The chosen nanoparticle formulation has a 294 nm average diameter with a 0.380 polidispersity index (PDI). In vitro characterization of scaffolds was performed by mechanical, morphological characterization, swelling capacity, Differential Scanning Calorimetry (DSC), Fourier-Transform Infrared Spectroscopy (FT-IR) measurements, and biocompatibility was evaluated by cell culture studies. Swelling index, tensile strength, elongation at break, and Young modulus of the β -TCP and silk nanoparticles loaded scaffold were found as 456%, 1.476 MPa, 6.75%, and 24 MPa, respectively. In vitro cell culture studies have shown that scaffolds prepared in the present study can accelerate osteoblast differentiation and increase the healing rate of bone tissues. In addition, they have the potential to be used as a drug delivery system in bone tissue engineering that needs to be evaluated with further studies.
- 14 January 2022
- Published by Duzce Universitesi Saglik Bilimleri Enstitusu Dergisi in Sağlık Bilimlerinde Değer
- Vol. 12 (1) , 28-35
Venlafaksin Hidroklorürün Uzatılmış Salım Yapan Tablet Formülasyonlarının Geliştirilmesi ve Değerlendirilmesi
Amaç: Depresyon, 250 milyondan fazla insanı yaştan bağımsız olarak etkileyen mental bozukluktur. Venlafaksin, antidepresan bir ilaçtır ve eski antidepresan ilaçlara göre daha az yan etki ile panik atak ve anksiyete tedavisinde kullanılır. Bununla birlikte, venlafaksin hidroklorür (VH), yeterli plazma-ilaç konsantrasyonunu sağlamak için günde üç kez dozlama gerektiren kısa yarı ömre sahiptir. Bu çalışmanın amacı, günde bir kez verilecek uzun süreli salım yapan VH tabletleri geliştirmektir. Gereç ve Yöntemler: Kontrollü salım ajanı olarak polietilen oksit, sodyum aljinat, hidroksipropil metil selüloz, guar zamkı ve poliakrilik asit kullanıldı. Tabletler doğrudan basım yöntemi ile hazırlandı. Toz (yığın açısı, akış hızı, Carr indeksi ve Hausner oranı) ve tablet (ağırlık homojenliği, sertlik, friabilite) karakterizasyonları değerlendirildi. 24 saat boyunca in vitro salım çalışmaları yapıldı ve ilaç salım kinetikleri farklı modeller kullanılarak değerlendirildi. Bulgular: Guar zamkı ile hazırlanan formülasyon dışında tüm formülasyonlar uygun Carr indeksi ve Hausner oranı gösterdi. Doğrudan basım yöntemi ile üretilen tabletler, ticari tablet ile karşılaştırıldı. Tüm formülasyonlar için uzun süreli VH salımı gözlendi. In vitro salım hızı test sonuçlarına göre, HPMC ve Carbopol polimerlerini içeren F1 formülasyonundan ilaç salımı, ticari tabletlere kıyasla benzer bulunmuştur. Sonuç: Doğrudan basılmış VH tabletler, hasta uyumu ve diğer üretim yöntemlerine kıyasla daha az üretim aşaması ile ticari tabletlere tercih edilebilir bir alternatif olabilir.
- 14 January 2022
- Published by Duzce Universitesi Saglik Bilimleri Enstitusu Dergisi in Sağlık Bilimlerinde Değer
- Vol. 12 (1) , 28-35
Venlafaksin Hidroklorürün Uzatılmış Salım Yapan Tablet Formülasyonlarının Geliştirilmesi ve Değerlendirilmesi
Amaç: Depresyon, 250 milyondan fazla insanı yaştan bağımsız olarak etkileyen mental bozukluktur. Venlafaksin, antidepresan bir ilaçtır ve eski antidepresan ilaçlara göre daha az yan etki ile panik atak ve anksiyete tedavisinde kullanılır. Bununla birlikte, venlafaksin hidroklorür (VH), yeterli plazma-ilaç konsantrasyonunu sağlamak için günde üç kez dozlama gerektiren kısa yarı ömre sahiptir. Bu çalışmanın amacı, günde bir kez verilecek uzun süreli salım yapan VH tabletleri geliştirmektir. Gereç ve Yöntemler: Kontrollü salım ajanı olarak polietilen oksit, sodyum aljinat, hidroksipropil metil selüloz, guar zamkı ve poliakrilik asit kullanıldı. Tabletler doğrudan basım yöntemi ile hazırlandı. Toz (yığın açısı, akış hızı, Carr indeksi ve Hausner oranı) ve tablet (ağırlık homojenliği, sertlik, friabilite) karakterizasyonları değerlendirildi. 24 saat boyunca in vitro salım çalışmaları yapıldı ve ilaç salım kinetikleri farklı modeller kullanılarak değerlendirildi. Bulgular: Guar zamkı ile hazırlanan formülasyon dışında tüm formülasyonlar uygun Carr indeksi ve Hausner oranı gösterdi. Doğrudan basım yöntemi ile üretilen tabletler, ticari tablet ile karşılaştırıldı. Tüm formülasyonlar için uzun süreli VH salımı gözlendi. In vitro salım hızı test sonuçlarına göre, HPMC ve Carbopol polimerlerini içeren F1 formülasyonundan ilaç salımı, ticari tabletlere kıyasla benzer bulunmuştur. Sonuç: Doğrudan basılmış VH tabletler, hasta uyumu ve diğer üretim yöntemlerine kıyasla daha az üretim aşaması ile ticari tabletlere tercih edilebilir bir alternatif olabilir.
- 1 April 2020
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 148, 1084-1097
Peptide-protein based nanofibers in pharmaceutical and biomedical applications
- 1 April 2020
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 148, 1084-1097
Peptide-protein based nanofibers in pharmaceutical and biomedical applications
- 4 June 2019
- Published by Taylor & Francis in Pharmaceutical Development and Technology
- Vol. 24 (7) , 864-873
Development and characterization of rapid dissolving ornidazole loaded PVP electrospun fibers
Gingivitis is a common and mild form of periodontal disease and can be described as a limited inflammation of the gingiva. This study aims to develop and characterize rapid releasing mucoadhesive fibers containing ornidazole with electrospinning process for the treatment of gingivitis. Polyvinylpyrrolidone (PVP) was chosen as a polymer and used at different concentrations of 10%, 12.5% and 15%. Scanning electron microscopy images showed that fiber diameters increased with increasing polymer concentrations. Tensile strength and elongation at break values of fibers increased with increasing PVP amount, whereas the loading of ornidazole into the fibers decreased these parameters. The contact angle values of all fibers were found to be 0° due to the hydrophilic nature of PVP. Ornidazole was released within 5 minutes and diffused from all of the fibers faster than that of gel and solution formulations. Electrospun ornidazole fibers were found efficient against Porphyromonas gingivalis in antimicrobial activity studies. The results demonstrated that ornidazole loaded fibers could be a potential drug delivery system for the treatment of gingivitis.
- 4 June 2019
- Published by Taylor & Francis in Pharmaceutical Development and Technology
- Vol. 24 (7) , 864-873
Development and characterization of rapid dissolving ornidazole loaded PVP electrospun fibers
Gingivitis is a common and mild form of periodontal disease and can be described as a limited inflammation of the gingiva. This study aims to develop and characterize rapid releasing mucoadhesive fibers containing ornidazole with electrospinning process for the treatment of gingivitis. Polyvinylpyrrolidone (PVP) was chosen as a polymer and used at different concentrations of 10%, 12.5% and 15%. Scanning electron microscopy images showed that fiber diameters increased with increasing polymer concentrations. Tensile strength and elongation at break values of fibers increased with increasing PVP amount, whereas the loading of ornidazole into the fibers decreased these parameters. The contact angle values of all fibers were found to be 0° due to the hydrophilic nature of PVP. Ornidazole was released within 5 minutes and diffused from all of the fibers faster than that of gel and solution formulations. Electrospun ornidazole fibers were found efficient against Porphyromonas gingivalis in antimicrobial activity studies. The results demonstrated that ornidazole loaded fibers could be a potential drug delivery system for the treatment of gingivitis.